Capital Square’s Corteva CTVA Stock Holding History

Capital Square’s Portfolio CTVA Stock Details CTVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-861	Closed	-$20K	–	170
2020 Q1	$20K	Buy	+861	New	+$23.7K	0.02%	296

Other funds holding CTVA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

IFP

Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Square's CTVA Position: Q2 2020 in Review

Capital Square sold out of Corteva (CTVA) in Q2 2020, closing a stake of 861 shares — an estimated $20K sold.

Capital Square first reported a position in CTVA in Q1 2020 and held it in 1 quarter. The position peaked at $20K in Q1 2020. 919 funds tracked by Wall St. Rank hold CTVA as of Q2 2020.

Capital Square reported no remaining Corteva position as of Q2 2020 after selling out during the quarter.
Capital Square sold 861 Corteva shares in Q2 2020, an estimated $20K.
Capital Square first reported a position in Corteva in Q1 2020 and held it in 1 quarter.
Capital Square's Corteva position peaked at $20K in Q1 2020.
919 funds tracked by Wall St. Rank held Corteva as of Q2 2020.

Based on Capital Square's 13F filing for Q2 2020, filed 27 Jul 2020.